Royal jelly fatty acids modulate proliferation and cytokine production by human peripheral blood mononuclear cells

European Food Research and Technology

Volumn 238, Issue 5, 2014, Pages 881-887

  Mihajlovic, Dusan ^a,b   Vucevic, Dragana ^a,c   Chinou, Ioanna ^d   Colic, Miodrag ^a,e  

^a Serbia   (Serbia)

^b UNIVERSITY OF KRAGUJEVAC   (Serbia)

^c UNIVERSITY OF DEFENCE   (Serbia)

^d UNIVERSITY OF ATHENS   (Greece)

^e UNIVERSITY OF NI   (Serbia)

Author keywords

10 Hydroxy trans 2 decenoic acid; 3,10 Dihydroxy decanoic acid; Cytokine; Fatty acid; Human PBMCs; Royal jelly

Indexed keywords

DIRECTIVE ANTENNAS; FATTY ACIDS; GLYCOPROTEINS; SATURATED FATTY ACIDS;

CYTOKINE PRODUCTION; CYTOKINES; DOSE-DEPENDENT; HUMAN PBMCS; HUMAN PERIPHERAL BLOOD; IMMUNOMODULATORY EFFECTS; ROYAL JELLY; TUMOR NECROSIS FACTORS;

INTERFERONS;

EID: 84900337181     PISSN: 14382377     EISSN: 14382385     Source Type: Journal    
DOI: 10.1007/s00217-014-2154-7     Document Type: Article

References (41)

1. Ramadan MF, Al-Ghamdi A (2012) Bioactive compounds and health-promoting properties of royal jelly: a review. J Funct Foods 4: 39-52.
2. Viuda-Martos M, Ruiz-Navajas Y, Fernández-López J, Pérez-Álvarez JA (2008) Functional properties of honey, propolis, and royal jelly. J Food Sci 73: R117-R124.
3. Bincoletto C, Eberlin S, Figueiredo CA, Luengo MB, Queiroz ML (2005) Effects produced by Royal Jelly on haematopoiesis: relation with host resistance against Ehrlich ascites tumour challenge. Int Immunopharmacol 5: 679-688.
4. Gasic S, Vucevic D, Vasilijic S, Antunovic M, Chinou I, Colic M (2007) Evaluation of the immunomodulatory activities of royal jelly components in vitro. Immunopharmacol Immunotoxicol 29: 521-536.
5. Vucevic D, Melliou E, Vasilijic S, Gasic S, Ivanovski P, Chinou I, Colic M (2007) Fatty acids isolated from royal jelly modulate dendritic cell-mediated immune response in vitro. Int Immunopharmacol 7: 1211-1220.
6. Dzopalic T, Vucevic D, Tomic S, Djokic J, Chinou I, Colic M (2011) 3, 10-Dihydroxy-decanoic acid, isolated from royal jelly, stimulates Th1 polarising capability of human monocyte-derived dendritic cells. Food Chem 126: 1211-1217.
7. Mihajlovic D, Rajkovic I, Chinou I, Colic M (2013) Dose-dependent immunomodulatory effects of 10-hydroxy-2-decenoic acid on human monocyte-derived dendritic cells. J Funct Foods 5: 838-846.
8. Okamoto I, Taniguchi Y, Kunikata T, Kohno K, Iwaki K, Ikeda M, Kurimoto M (2003) Major royal jelly protein 3 modulates immune responses in vitro and in vivo. Life Sci 73: 2029-2045.
9. Majtan J, Kovacova E, Bilikova K, Simuth J (2006) The immunostimulatory effect of the recombinant apalbumin 1-major honeybee royal jelly protein-on TNFalpha release. Int Immunopharmacol 6: 269-278.
10. Kohno K, Okamoto I, Sano O, Arai N, Iwaki K, Ikeda M, Kurimoto M (2004) Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages. Biosci Biotechnol Biochem 68: 138-145.
11. Mannoor MK, Shimabukuro I, Tsukamotoa M, Watanabe H, Yamaguchi K, Sato Y (2009) Honeybee royal jelly inhibits autoimmunity in SLE-prone NZB × NZW F1 mice. Lupus 18: 44-52.
12. Matsui T, Yukiyoshi A, Doi S, Sugimoto H, Yamada H, Matsumoto K (2002) Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR. J Nutr Biochem 13: 80-86.
13. Fontana R, Mendes MA, de Souza BM, Konno K, Cesar LM, Malaspina O, Palma MS (2004) Jelleines: a family of antimicrobial peptides from the Royal Jelly of honeybees (Apis mellifera). Peptides 25: 919-928.
14. Oka H, Emori Y, Kobayashi N, Hayashi Y, Nomoto K (2001) Suppression of allergic reactions by royal jelly in association with the restoration of macrophage function and the improvement of Th1/Th2 cell responses. Int Immunopharmacol 1: 521-532.
15. Jamnik P, Goranovic D, Raspor P (2007) Antioxidative action of royal jelly in the yeast cell. Exp Gerontol 42: 594-600.
16. Melliou E, Chinou I (2005) Chemistry and bioactivity of royal jelly from Greece. J Agric Food Chem 53: 8987-8992.
17. Isidorov VA, Czyżewska U, Jankowska E, Bakier S (2011) Determination of royal jelly acids in honey. Food Chem 124: 387-391.
18. Jenny M, Klieber M, Zaknun D, Schroecksnadel S, Kurz K, Ledochowski M, Schennach H, Fuchs D (2011) In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors. Inflamm Res 60: 127-135.
19. Zhu J, Yamane H, Paul WE (2010) Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 28: 445-489.
20. Erem C, Deger O, Ovali E, Barlak Y (2006) The effects of royal jelly on autoimmunity in Graves' disease. Endocrine 30: 175-183.
21. Karaca T, Bayiroglu F, Yoruk M, Kaya MS, Uslu S, Comba B, Mis L (2010) Effect of royal jelly on experimental colitis Induced by acetic acid and alteration of mast cell distribution in the colon of rats. Eur J Histochem 54: e35.
22. Sugiyama T, Takahashi K, Mori H (2012) Royal jelly acid, 10-hydroxy-trans-2-decenoic acid, as a modulator of the innate immune responses. Endocr Metab Immune Disord Drug Targets 12: 368-376.
23. Sugiyama T, Takahashi K, Kuzumaki A, Tokoro S, Neri P, Mori H (2013) Inhibitory mechanism of 10-hydroxy-trans-2-decenoic acid (royal jelly acid) against lipopolysaccharide- and interferon-beta-induced nitric oxide production. Inflammation 36: 372-378.
24. Takahashi K, Sugiyama T, Tokoro S, Neri P, Mori H (2012) Inhibition of interferon-gamma-induced nitric oxide production by 10-hydroxy-trans-2-decenoic acid through inhibition of interferon regulatory factor-8 induction. Cell Immunol 273: 73-78.
25. Sugiyama T, Takahashi K, Tokoro S, Gotou T, Neri P, Mori H (2012) Inhibitory effect of 10-hydroxy-trans-2-decenoic acid on LPS-induced IL-6 production via reducing IkappaB-zeta expression. Innate Immun 18: 429-437.
26. Vallabhapurapu S, Karin M (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27: 693-733.
27. Zubiaga AM, Munoz E, Merrow M, Huber BT (1990) Regulation of interleukin 6 production in T helper cells. Int Immunol 2: 1047-1054.
28. Romagnani S, Maggi E, Liotta F, Cosmi L, Annunziato F (2009) Properties and origin of human Th17 cells. Mol Immunol 47: 3-7.
29. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245-252.
30. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG (2011) Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 29: 71-109.
31. Petursdottir DH, Hardardottir I (2009) Dietary fish oil decreases secretion of T helper (Th) 1-type cytokines by a direct effect on murine splenic T cells but enhances secretion of a Th2-type cytokine by an effect on accessory cells. Br J Nutr 101: 1040-1046.
32. Yang XY, Yang DS, Wei Z, Wang JM, Li CY, Hui Y, Lei KF, Chen XF, Shen NH, Jin LQ, Wang JG (2010) 10-Hydroxy-2-decenoic acid from Royal jelly: a potential medicine for RA. J Ethnopharmacol 128: 314-321.
33. Georgiadi A, Kersten S (2012) Mechanisms of gene regulation by fatty acids. Adv Nutr 3: 127-134.
34. da Rocha Junior LF, Dantas AT, Duarte AL, de Melo Rego MJ, Pitta Ida R, Pitta MG (2013) PPAR gamma agonists in adaptive immunity: what do immune disorders and their models have to tell us? PPAR Res 2013: 519724.
35. Malapaka RR, Khoo S, Zhang J, Choi JH, Zhou XE, Xu Y, Gong Y, Li J, Yong EL, Chalmers MJ, Chang L, Resau JH, Griffin PR, Chen YE, Xu HE (2012) Identification and mechanism of 10-carbon fatty acid as modulating ligand of peroxisome proliferator-activated receptors. J Biol Chem 287: 183-195.
36. Jiang C, Ting AT, Seed B (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86.
37. Kim DI, Kim KH, Kang JH, Jung EM, Kim SS, Jeung EB, Yang MP (2011) Trans-10, cis-12-conjugated linoleic acid modulates NF-kappaB activation and TNF-alpha production in porcine peripheral blood mononuclear cells via a PPARgamma-dependent pathway. Br J Nutr 105: 1329-1336.
38. Klotz L, Burgdorf S, Dani I, Saijo K, Flossdorf J, Hucke S, Alferink J, Nowak N, Beyer M, Mayer G, Langhans B, Klockgether T, Waisman A, Eberl G, Schultze J, Famulok M, Kolanus W, Glass C, Kurts C, Knolle PA (2009) The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J Exp Med 206: 2079-2089.
39. Liberato MV, Nascimento AS, Ayers SD, Lin JZ, Cvoro A, Silveira RL, Martinez L, Souza PC, Saidemberg D, Deng T, Amato AA, Togashi M, Hsueh WA, Phillips K, Palma MS, Neves FA, Skaf MS, Webb P, Polikarpov I (2012) Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) gamma activators and pan-PPAR partial agonists. PLoS ONE 7: e36297.
40. Wang J, Wu X, Simonavicius N, Tian H, Ling L (2006) Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J Biol Chem 281: 34457-34464.
41. Suzuki M, Takaishi S, Nagasaki M, Onozawa Y, Iino I, Maeda H, Komai T, Oda T (2013) Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor. J Biol Chem 288: 10684-10691.